Newswise — PHILADELPHIA, PA - Clarivate Analytics, formerly the Intellectual Property & Science business of Thomson Reuters announces its third place win with Georgetown University in the USPTO Cancer Moonshot Challenge held by the U.S. Commerce Department’s United States Patent and Trademark Office (USPTO).
Launched by the USPTO in August, the competition aimed to reveal new insights from patent data in support of the goals of the National Cancer Moonshot initiative: to accelerate the development of patient-focused cancer treatments, increase patient access to clinical trials and therapies and align public-private policies and investment to improve the ability to prevent cancer and detect it at an early stage. Participants built visualizations leveraging a dataset developed by the USPTO, to reveal trends and gain insights to guide public policy and research in cancer.
Clarivate, with Georgetown Lombardi Comprehensive Cancer Center, developed the Innovation Visualization and Understanding for Cancer Tool (Cancer InnovationVU). The interactive resource, built on data integrated in the ScienceWire® platform, combines timelines of patenting and funding with data on the epidemiology of cancer in the United States. The platform was used by the NIH, NSF and others and facilitates evaluation and decision-making for science. Users of Cancer InnovationVU explore relationships among patents, research funding and cancer incidence and mortality. USPTO acknowledged Cancer InnovationVU for illustrating how “the epidemiology of cancer mortality relates to patenting and funding timelines.”
“We are delighted to be recognized by the USPTO along with the Georgetown Lombardi Comprehensive Cancer Center,” said Chris McKenna, general manager, Discovery Science at Clarivate. “This challenge demonstrates the value in democratizing data, using analytics to reveal new insights into cancer trends and in difficult to study relationships across data otherwise operating on different timescales.”
“We need to leave no stone unturned as we pursue new approaches in preventing, diagnosing and treating cancer,” said team member Chiranjeev Dash, M.B.B.S., Ph.D., associate professor of oncology at Georgetown Lombardi. “The success of the National Cancer Moonshot initiative will depend on our ability to forge collaborations between academia, industry and government to not only generate new data, but to more effectively mine the high-quality data already available to us.”
The award-winning team consisted of Di Cross, Director of Research Analytics and Eugene Rakhmatulin, Senior Director of Enabling Technologies & Informatics Delivery, and Dash from Georgetown Lombardi.
Clarivate Analytics
ClarivateTM Analytics accelerates the pace of innovation by providing trusted insights and analytics to customers around the world, enabling them to discover, protect and commercialize new ideas, faster. Formerly the Intellectual Property and Science business of Thomson Reuters, we’ve been assisting our customers for over 60 years. Now as an independent company with over 4,000 employees, operating in more than 100 countries around the world, we remain expert, objective and agile. For more information, please visit us at Clarivate.com.
RSS